Table 3.
Population pharmacokinetic parameters of ceftriaxone
| Estimation | Bootstrap | ||||||
|---|---|---|---|---|---|---|---|
| Parameter | Final estimate | SE of the estimate | 95% CI* | Median | 95% CI† | ||
| PK | |||||||
| CL (l h−1) = θ1+θ2× (CLcr/4.26) | |||||||
| θ1 | 0.56 | 0.11 | 0.34 | 0.78 | 0.56 | 0.37 | 0.85 |
| θ2 | 0.32 | 0.12 | 0.08 | 0.56 | 0.32 | 0.005 | 0.56 |
| V1 (l) | 10.3 | 0.89 | 8.56 | 12.04 | 10.0 | 6.24 | 13.4 |
| V2 (l) | 7.35 | 0.75 | 5.88 | 8.82 | 7.48 | 4.81 | 10.9 |
| Q (l h−1) | 5.28 | 1.37 | 2.59 | 7.97 | 5.12 | 1.16 | 14.4 |
| BSV ω2 (% coefficient variation) | |||||||
| ω2 (CL) | 0.24 (49) | 0.05 | 0.14 | 0.34 | 0.25 | 0.15 | 0.38 |
| ω2 (V1) | 0.23 (48) | 0.06 | 0.11 | 0.35 | 0.24 | 0.11 | 0.43 |
| ω2 (V2) | 0.42 (65) | 0.11 | 0.20 | 0.64 | 0.38 | 0.18 | 1.76 |
| Residual variability σ2 | |||||||
| σ2 proportional (%) | 24 | 0.009 | 21 | 28 | 24 | 21 | 28 |
(mean estimate ± 1.96 SE of the estimates) for θ; (mean estimate ± 1.96 SE of the estimates)1/2 for ω and σ.
The 2.5th and 97.5th percentiles of 500 bootstrap distribution of parameter estimates. V1, volume of the central compartment; V2, volume of the peripheral compartment; CL, clearance of ceftriaxone; CLcr, clearance of creatinine; Q, intercompartmental clearance.